Excess cholesterol deposit in the brain was demonstrated to be related to an increase of Aβ plaques and amyloid cascade leading to synaptic plasticity annihilation and promotion of tau phosphorylation, hence contributing to the risk of AD pathogenesis, possibly in an early phase [86, 87]. The gene discussed is MAPT; the disease is Alzheimer disease.